Table 3.
Baseline |
Hour 2 |
Hour 12 |
Hour 22 |
|||||
---|---|---|---|---|---|---|---|---|
treatment | Placebo | treatment | Placebo | treatment | Placebo | treatment | Placebo | |
CRP | 0.89 ± 0.97 | 0.72 ± 0.88 | 0.90 ± 0.92 | 0.72 ± 0.82 | 0.83 ± 0.72 | 0.68 ± 0.79 | 0.86 ± 0.87 | 0.73 ± 0.85 |
Inflammatory cytokine panel | ||||||||
TNF-α | 4.74 ± 1.10 | 5.07 ± 1.39 | 4.74 ± 1.03 | 5.00 ± 1.25 | 4.25 ± 1.14 | 4.52 ± 0.74 | 5.16 ± 1.68 | 5.30 ± 1.16 |
IL-1β | 8.27 ± 3.73 | 7.81 ± 1.88 | 7.32 ± 1.79 | 7.82 ± 1.84 | 7.48 ± 1.79 | 7.60 ± 2.09 | 8.47 ± 1.92 | 8.40 ± 2.73 |
IL-2 | 4.17 ± 0.65 | 4.48 ± 0.83 | 4.15 ± 0.51 | 4.23 ± 0.84 | 4.01 ± 0.65 | 3.96 ± 0.64 | 4.43 ± 0.91 | 4.71 ± 1.14 |
IL-4 | 5.39 ± 1.60 | 5.09 ± 1.10 | 5.08 ± 1.56 | 5.27 ± 1.44 | 4.76 ± 1.57 | 4.79 + 0.63 | 5.92 ± 2.26 | 5.21 ± 1.07 |
IL-5 | 4.36 ± 1.55 | 4.16 ± 0.98 | 405 ± 1.07 | 4.67 ± 1.05 | 3.90 ± 1.00 | 4.45 ± 1.79 | 4.15 ± 0.94 | 4.70 ± 1.75 |
IL-6 | 2.94 ± 0.26 | 3.02 ± 0.05 | 3.02 ± 0.05 | 3.02 ± 0.05 | 3.00 ± 0.38 | 2.97 ± 0.13 | 3.27 ± 0.46 | 3.06 ± 0.14 |
IL-8 | 4.83 ± 0.79 | 5.24 ± 1.07 | 4.68 ± 0.73 | 4.77 ± 0.78 | 8.72 ± 4.84 | 5.69 ± 1.40 | 5.28 ± 0.68 | 4.19 ± 0.81# |
IL-10 | 3.82 ± 0.61 | 4.35 ± 0.76 | 4.15 ± 0.62 | 4.04 ± 0.56 | 3.92 ± 0.40 | 4.10 ± 0.71 | 4.09 ± 0.45 | 4.23 ± 0.71# |
IL-12p70 | 3.98 ± 0.80 | 4.99 ± 1.49 | 4.30 ± 0.70 | 4.48 ± 0.65 | 4.02 ± 0.54 | 4.41 ± 0.96 | 4.54 ± 0.84 | 4.62 ± 0.64# |
IL-13 | 4.88 ± 0.94 | 4.84 ± 0.88 | 4.90 ± 0.96 | 5.21 ± 1.03 | 4.70 ± 0.74 | 4.61 ± 0.82 | 4.84 ± 0.84 | 5.11 ± 0.99 |
IL-17A | 3.61 ± 0.47 | 3.87 ± 0.74 | 3.63 ± 0.48 | 3.73 ± 0.46 | 4.00 ± 0.53 | 3.68 ± 0.45 | 3.53 ± 0.52 | 3.67 ± 0.49 |
GM-CSF factor | 5.87 ± 0.99 | 5.84 ± 0.53 | 5.55 ± 0.48 | 6.24 ± 0.78 | 5.51 ± 0.63 | 5.85 ± 0.80 | 6.27 ± 1.16 | 6.23 ± 1.01 |
Eotaxin | 54.10 ± 39.89 | 68.67 ± 44.12 | 61.07 ± 50.93 | 55.02 ± 30.01 | 90.33 ± 61.2 | 92.93 ± 62.66 | 98.57 ± 67.84 | 87 ± 61.56 |
MIP-1beta | 422.67 ± 161.14 | 410.72 ± 171.99 | 411.07 ± 195.48 | 381.52 ± 176.67 | 556.52 ± 183.08 | 586.23 ± 222.62 | 462.71 ± 145.04 | 485.18 ± 197.25 |
IFN-γ | 5.67 ± 1.77 | 6.40 ± 2.10 | 5.66 ± 1.63 | 5.49 ± 1.26 | 5.54 ± 2.04 | 6.03 ± 2.62 | 5.78 ± 1.91 | 6.18 ± 2.32 |
VEGF | 47.86 ± 24.02 | 61.67 ± 40.74 | 45.65 ± 24.23 | 51.33 ± 30.81 | 57.64 ± 37.68 | 64.72 ± 44.88 | 54.89 ± 29.34 | 62.12 ± 37.67 |
MCP-1 | 16.43 ± 6.31 | 15.54 ± 4.66 | 14.35 ± 5.09 | 15.15 ± 4.66 | 18.28 ± 5.21 | 20.64 ± 8.28 | 16.8 ± 4.67 | 17.55 ± 5.80 |
FGF-basic | 4.31 ± 0.46 | 4.46 ± 0.51 | 4.30 ± 0.59 | 4.50 ± 0.56 | 4.55 ± 0.89 | 4.32 ± 0.46 | 4.70 ± 0.45 | 4.51 ± 0.50 |
Liver function tests | ||||||||
AST | 21.8 ± 8.61 | 18.13 ± 5.30 | 21.6 ± 8.26 | 18.87 ± 5.14 | 18.79 ± 6.58 | 17.07 ± 3.9 | 17.08 ± 4.91 | 17.27 ± 3.84 |
ALT | 18.13 ± 8.79 | 16 ± 5.68 | 18.33 ± 8.74 | 16.13 ± 5.65 | 16.21 ± 8.38 | 15.4 ± 5.15 | 15.92 ± 8.25 | 15.53 ± 5.64 |
Total bilirubin | 0.51 ± 0.2 | 0.49 ± 0.22 | 0.48 ± 0.15 | 0.47 ± 0.17 | 0.42 ± 0.15 | 0.39 ± 0.12 | 0.59 ± 0.21 | 0.54 ± 0.22 |
Albumin | 4.53 ± 0.29 | 4.41 ± 0.32 | 4.59 ± 0.35 | 4.45 ± 0.34 | 4.36 ± 0.35 | 4.36 ± 0.43 | 4.41 ± 0.31 | 4.45 ± 0.41 |
INR | 1.04 ± 0.07 | 1.03 ± 006 | 1.03 ± 0.07 | 1.04 ± 0.06 | 1.06 ± 0.11 | 1.07 ± 0.09 | 1.06 ± 0.08 | 62.47 ± 14.88 |
ALK | 63.88 ± 13.08 | 67.44 ± 14.17 | 66.31 ± 14.62 | 69.84 ± 13.31 | 62.84 ± 14.76 | 67.41 ± 15.23 | 62.47 ± 14.88 | 67.88 ± 15.61 |
GSH-Px | 69.89 ± 15.77 | 74.69 ± 16.18 | 70.46 ± 15.52 | 71.48 ± 14.27 | 70.79 ± 9.60 | 75.3 ± 13.26 | 73.79 ± 11.66 | 76.86 ± 12.88 |
# p < 0.05, Denotes significant difference of active compared to placebo.